Search

Search Results
Results 4531 - 4540 of 4833 for Movement Disorder
  • Afinitor
    Drug - 21 Mar 2024
    Consumer Medicine Information (CMI) about Afinitor intended for persons living in Australia.
  • Anti-Pollution Skincare: Protecting Skin in Urban Environments
    Health - 7 Feb 2024
    Frequent exposure to high levels of air pollutants can lead to premature aging, photodamage, patchy skin, solar lentigo, atopic dermatitis, psoriasis, and even skin cancers.
  • Stilnox CR
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Stilnox CR intended for persons living in Australia.
  • Enspryng
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Enspryng intended for persons living in Australia.
  • Trifeme
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Trifeme intended for persons living in Australia.
  • DBL Rocuronium Bromide Injection
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Rocuronium Bromide Injection intended for persons living in Australia.
  • Rapamune Tablets
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Tablets intended for persons living in Australia.
  • Rapamune Oral Solution
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Rapamune Oral Solution intended for persons living in Australia.
  • DBL Phenytoin Injection BP
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about DBL Phenytoin Injection BP intended for persons living in Australia.
  • Minulet
    Drug - 28 Jan 2024
    Consumer Medicine Information (CMI) about Minulet intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback